New asthma pill shows promise in early trial

NCT ID NCT07301255

Recruiting now Symptom relief Sponsor: Enveda Therapeutics Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jul 30, 2026 · Updated 3 times

Summary

This study tests an experimental oral drug called ENV-294 in 50 adults with moderate-to-severe asthma who already use standard inhalers. Participants take either the drug or a placebo once daily for 12 weeks. The goal is to see if the drug improves asthma control and lung function safely.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ENV-294 (an oral drug taken as a tablet once daily)
What this could lead to: If successful, this could lead to a new daily pill that helps control asthma symptoms and reduce flare-ups in people with moderate-to-severe asthma.
What could go wrong: This is an early Phase 2 trial with only 50 participants, so results may not apply to everyone. The drug may not work better than placebo, and side effects are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

asthma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ASTHMA

Contacts and locations

Locations

Enveda Investigative Site
RECRUITING

Birmingham, Alabama, 35209, United States
Enveda Investigative Site
RECRUITING

Los Angeles, California, 90025, United States
Enveda Investigative Site
RECRUITING

San Jose, California, 95117, United States
Enveda Investigative Site
RECRUITING

West Hills, California, 91307, United States
Enveda Investigative Site
RECRUITING

Colorado Springs, Colorado, 80907, United States
Enveda Investigative Site
RECRUITING

Hialeah, Florida, 33012, United States
Enveda Investigative Site
RECRUITING

Miami, Florida, 33135, United States
Enveda Investigative Site
RECRUITING

Albany, Georgia, 31707, United States
Enveda Investigative Site
RECRUITING

Maryville, Illinois, 62062, United States
Enveda Investigative Site
RECRUITING

Kansas City, Kansas, 66160, United States
Enveda Investigative Site
RECRUITING

Owensboro, Kentucky, 42301, United States
Enveda Investigative Site
RECRUITING

Southfield, Michigan, 48075, United States
Enveda Investigative Site
RECRUITING

St Louis, Missouri, 63141, United States
Enveda Investigative Site
RECRUITING

Clackamas, Oregon, 97015, United States
Enveda Investigative Site
RECRUITING

Medford, Oregon, 97504, United States
Enveda Investigative Site
RECRUITING

North Charleston, South Carolina, 29406, United States
Enveda Investigative Site
RECRUITING

McKinney, Texas, 75069, United States
Enveda Investigative Site
NOT_YET_RECRUITING

Madison, Wisconsin, 53792, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.